Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase

Makoto Chuma, Naoya Sakamoto, Akira Nakai, Shuhei Hige, Mitsuru Nakanishi, Mitsuteru Natsuizaka, Goki Suda, Takuya Sho, Kanako Hatanaka, Yoshihiro Matsuno, Hideki Yokoo, Toshiya Kamiyama, Akinobu Taketomi, Gen Fujii, Kosuke Tashiro, Yoko Hikiba, Mitsuaki Fujimoto, Masahiro Asaka, Shin Maeda

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Heat shock factor 1 (HSF1), a major transactivator of stress responses, has been implicated in carcinogenesis in various organs. However, little is known about the biological functions of HSF1 in the development of hepatocellular carcinoma (HCC). To clarify the functional role of HSF1 in HCC, we established HSF1-knockdown (HSF1 KD) KYN2 HCC cells by stably expressing either small hairpin RNA (shRNA) against HSF1 (i.e. HSF1 KD) or control shRNA (HSF1 control). Tumorigenicity was significantly reduced in orthotopic mice with HSF1 KD cells compared with those with HSF1 control cells. Reduced tumorigenesis in HSF1 KD cells appeared attributable to increased apoptosis and decreased proliferation. Tumor necrosis factor-α-induced apoptosis was increased in HSF1 KD cells and HSF1-/- mouse hepatocytes compared with controls. Decreased expression of IκB kinase γ, a positive regulator of nuclear factor-κB, was also observed in HSF1 KD cells and HSF1-/- mouse hepatocytes. Furthermore, expression of bcl-2-associated athanogene domain 3 (BAG3) was dramatically reduced in HSF1 KD cells and HSF1-/- mouse hepatocytes. We also found that epidermal growth factor-stimulated mitogenactivated protein kinase signaling was impaired in HSF1 KD cells. Clinicopathological analysis demonstrated frequent overexpression of HSF1 in human HCCs. Significant correlations between HSF1 and BAG3 protein levels and prognosis were also observed. In summary, these results identify a mechanistic link between HSF1 and liver tumorigenesis and may provide as a potential molecular target for the development of anti-HCC therapies.

Original languageEnglish
Article numberbgt343
Pages (from-to)272-281
Number of pages10
JournalCarcinogenesis
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 1 2014

Fingerprint

Mitogen-Activated Protein Kinases
Hepatocellular Carcinoma
Shock
Hot Temperature
Hepatocytes
Carcinogenesis
Small Interfering RNA
Apoptosis
Trans-Activators
Epidermal Growth Factor
Protein Kinases

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Chuma, M., Sakamoto, N., Nakai, A., Hige, S., Nakanishi, M., Natsuizaka, M., ... Maeda, S. (2014). Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase. Carcinogenesis, 35(2), 272-281. [bgt343]. https://doi.org/10.1093/carcin/bgt343

Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase. / Chuma, Makoto; Sakamoto, Naoya; Nakai, Akira; Hige, Shuhei; Nakanishi, Mitsuru; Natsuizaka, Mitsuteru; Suda, Goki; Sho, Takuya; Hatanaka, Kanako; Matsuno, Yoshihiro; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Fujii, Gen; Tashiro, Kosuke; Hikiba, Yoko; Fujimoto, Mitsuaki; Asaka, Masahiro; Maeda, Shin.

In: Carcinogenesis, Vol. 35, No. 2, bgt343, 01.02.2014, p. 272-281.

Research output: Contribution to journalArticle

Chuma, M, Sakamoto, N, Nakai, A, Hige, S, Nakanishi, M, Natsuizaka, M, Suda, G, Sho, T, Hatanaka, K, Matsuno, Y, Yokoo, H, Kamiyama, T, Taketomi, A, Fujii, G, Tashiro, K, Hikiba, Y, Fujimoto, M, Asaka, M & Maeda, S 2014, 'Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase', Carcinogenesis, vol. 35, no. 2, bgt343, pp. 272-281. https://doi.org/10.1093/carcin/bgt343
Chuma, Makoto ; Sakamoto, Naoya ; Nakai, Akira ; Hige, Shuhei ; Nakanishi, Mitsuru ; Natsuizaka, Mitsuteru ; Suda, Goki ; Sho, Takuya ; Hatanaka, Kanako ; Matsuno, Yoshihiro ; Yokoo, Hideki ; Kamiyama, Toshiya ; Taketomi, Akinobu ; Fujii, Gen ; Tashiro, Kosuke ; Hikiba, Yoko ; Fujimoto, Mitsuaki ; Asaka, Masahiro ; Maeda, Shin. / Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase. In: Carcinogenesis. 2014 ; Vol. 35, No. 2. pp. 272-281.
@article{8bbc13a3c0e14bf1a959b20d85221e54,
title = "Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase",
abstract = "Heat shock factor 1 (HSF1), a major transactivator of stress responses, has been implicated in carcinogenesis in various organs. However, little is known about the biological functions of HSF1 in the development of hepatocellular carcinoma (HCC). To clarify the functional role of HSF1 in HCC, we established HSF1-knockdown (HSF1 KD) KYN2 HCC cells by stably expressing either small hairpin RNA (shRNA) against HSF1 (i.e. HSF1 KD) or control shRNA (HSF1 control). Tumorigenicity was significantly reduced in orthotopic mice with HSF1 KD cells compared with those with HSF1 control cells. Reduced tumorigenesis in HSF1 KD cells appeared attributable to increased apoptosis and decreased proliferation. Tumor necrosis factor-α-induced apoptosis was increased in HSF1 KD cells and HSF1-/- mouse hepatocytes compared with controls. Decreased expression of IκB kinase γ, a positive regulator of nuclear factor-κB, was also observed in HSF1 KD cells and HSF1-/- mouse hepatocytes. Furthermore, expression of bcl-2-associated athanogene domain 3 (BAG3) was dramatically reduced in HSF1 KD cells and HSF1-/- mouse hepatocytes. We also found that epidermal growth factor-stimulated mitogenactivated protein kinase signaling was impaired in HSF1 KD cells. Clinicopathological analysis demonstrated frequent overexpression of HSF1 in human HCCs. Significant correlations between HSF1 and BAG3 protein levels and prognosis were also observed. In summary, these results identify a mechanistic link between HSF1 and liver tumorigenesis and may provide as a potential molecular target for the development of anti-HCC therapies.",
author = "Makoto Chuma and Naoya Sakamoto and Akira Nakai and Shuhei Hige and Mitsuru Nakanishi and Mitsuteru Natsuizaka and Goki Suda and Takuya Sho and Kanako Hatanaka and Yoshihiro Matsuno and Hideki Yokoo and Toshiya Kamiyama and Akinobu Taketomi and Gen Fujii and Kosuke Tashiro and Yoko Hikiba and Mitsuaki Fujimoto and Masahiro Asaka and Shin Maeda",
year = "2014",
month = "2",
day = "1",
doi = "10.1093/carcin/bgt343",
language = "English",
volume = "35",
pages = "272--281",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase

AU - Chuma, Makoto

AU - Sakamoto, Naoya

AU - Nakai, Akira

AU - Hige, Shuhei

AU - Nakanishi, Mitsuru

AU - Natsuizaka, Mitsuteru

AU - Suda, Goki

AU - Sho, Takuya

AU - Hatanaka, Kanako

AU - Matsuno, Yoshihiro

AU - Yokoo, Hideki

AU - Kamiyama, Toshiya

AU - Taketomi, Akinobu

AU - Fujii, Gen

AU - Tashiro, Kosuke

AU - Hikiba, Yoko

AU - Fujimoto, Mitsuaki

AU - Asaka, Masahiro

AU - Maeda, Shin

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Heat shock factor 1 (HSF1), a major transactivator of stress responses, has been implicated in carcinogenesis in various organs. However, little is known about the biological functions of HSF1 in the development of hepatocellular carcinoma (HCC). To clarify the functional role of HSF1 in HCC, we established HSF1-knockdown (HSF1 KD) KYN2 HCC cells by stably expressing either small hairpin RNA (shRNA) against HSF1 (i.e. HSF1 KD) or control shRNA (HSF1 control). Tumorigenicity was significantly reduced in orthotopic mice with HSF1 KD cells compared with those with HSF1 control cells. Reduced tumorigenesis in HSF1 KD cells appeared attributable to increased apoptosis and decreased proliferation. Tumor necrosis factor-α-induced apoptosis was increased in HSF1 KD cells and HSF1-/- mouse hepatocytes compared with controls. Decreased expression of IκB kinase γ, a positive regulator of nuclear factor-κB, was also observed in HSF1 KD cells and HSF1-/- mouse hepatocytes. Furthermore, expression of bcl-2-associated athanogene domain 3 (BAG3) was dramatically reduced in HSF1 KD cells and HSF1-/- mouse hepatocytes. We also found that epidermal growth factor-stimulated mitogenactivated protein kinase signaling was impaired in HSF1 KD cells. Clinicopathological analysis demonstrated frequent overexpression of HSF1 in human HCCs. Significant correlations between HSF1 and BAG3 protein levels and prognosis were also observed. In summary, these results identify a mechanistic link between HSF1 and liver tumorigenesis and may provide as a potential molecular target for the development of anti-HCC therapies.

AB - Heat shock factor 1 (HSF1), a major transactivator of stress responses, has been implicated in carcinogenesis in various organs. However, little is known about the biological functions of HSF1 in the development of hepatocellular carcinoma (HCC). To clarify the functional role of HSF1 in HCC, we established HSF1-knockdown (HSF1 KD) KYN2 HCC cells by stably expressing either small hairpin RNA (shRNA) against HSF1 (i.e. HSF1 KD) or control shRNA (HSF1 control). Tumorigenicity was significantly reduced in orthotopic mice with HSF1 KD cells compared with those with HSF1 control cells. Reduced tumorigenesis in HSF1 KD cells appeared attributable to increased apoptosis and decreased proliferation. Tumor necrosis factor-α-induced apoptosis was increased in HSF1 KD cells and HSF1-/- mouse hepatocytes compared with controls. Decreased expression of IκB kinase γ, a positive regulator of nuclear factor-κB, was also observed in HSF1 KD cells and HSF1-/- mouse hepatocytes. Furthermore, expression of bcl-2-associated athanogene domain 3 (BAG3) was dramatically reduced in HSF1 KD cells and HSF1-/- mouse hepatocytes. We also found that epidermal growth factor-stimulated mitogenactivated protein kinase signaling was impaired in HSF1 KD cells. Clinicopathological analysis demonstrated frequent overexpression of HSF1 in human HCCs. Significant correlations between HSF1 and BAG3 protein levels and prognosis were also observed. In summary, these results identify a mechanistic link between HSF1 and liver tumorigenesis and may provide as a potential molecular target for the development of anti-HCC therapies.

UR - http://www.scopus.com/inward/record.url?scp=84893349967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893349967&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgt343

DO - 10.1093/carcin/bgt343

M3 - Article

C2 - 24130164

AN - SCOPUS:84893349967

VL - 35

SP - 272

EP - 281

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

M1 - bgt343

ER -